Latest Herpes zoster Stories
Patients reminded that benefits far outweigh risks CHICAGO, Aug. 5 /PRNewswire-USNewswire/ -- Vaccines have a long history of successfully preventing disease and, in effect, improving the lives of countless Americans.
COLUMBUS, Ohio, June 9 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the Abbreviated New Drug Application (ANDA) approval of Valacyclovir Hydrochloride Tablets 500mg and 1g as of May 24, 2010 by the Food and Drug Administration.
Fresh understanding of the virus that causes chickenpox and shingles could lead to improved vaccines and diagnostic tests, a study suggests.
BALTIMORE, May 6 /PRNewswire/ -- The American Pain Foundation (APF) announced today at the American Pain Society (APS) Annual Meeting the results of a national survey that showed postherpetic neuralgia (PHN), also known as after-shingles pain, continues to be a condition with low awareness amongst Americans, demonstrating a need for health care provider (HCP) intervention.
LaTroy Hawkins and the National Council on Aging Raise Awareness of Shingles and After-shingles Pain WASHINGTON, May 3 /PRNewswire-USNewswire/ -- The National Council on Aging (NCOA) today announced the launch of the 2010 Patchwork of Hope Network, an educational campaign to raise awareness of shingles and postherpetic neuralgia (PHN).
SAN MATEO, Calif., April 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that QutenzaÂ® (capsaicin) 8% patch, the first and only product containing prescription-strength capsaicin, is now available.
Having a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
Chicken pox vaccine may also reduce risk of shingles among children; study used electronic health records to follow 172,000 children.
OAKLAND, Calif., Dec.
SAN FRANCISCO, Nov. 18 /PRNewswire/ -- Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection.
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
- Inward knowledge; understanding; conscience.